Address Barriers to Treating Opioid Use Disorder During COVID-19

October 2020

You’ll hear that COVID-19 is eroding gains against the opioid epidemic...partly due to barriers to care, isolation, and stress.

About 1 in 3 patients with opioid use disorder (OUD) report changes or disruptions in care...such as trouble getting meds to treat OUD.

Make every effort to ensure patients have access.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote